Literature DB >> 4597622

Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

K E Hellström, I Hellström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4597622     DOI: 10.1016/s0065-2776(08)60311-9

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  102 in total

1.  Lymph Node Reaction to Cancer. (Immunohistochemical and Ultrastructural Study).

Authors:  Dmitry E Tsyplakov; Semion V Petrov; Roman N Kulagin
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  The role of the immune response in oncogenesis.

Authors:  H F Jeejeebhoy
Journal:  In Vitro       Date:  1975 May-Jun

Review 3.  Role of circulating soluble immune complexes in disease.

Authors:  R J Levinsky
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

4.  Tumours can act as adjuvants for humoral immunity.

Authors:  D M Brown; T L Fisher; C Wei; J G Frelinger; E M Lord
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

5.  The class of antibody involved in the antibody-dependent cell-mediated lysis of chicken erythrocytes.

Authors:  S Macphail
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

Review 6.  Immunopathology.

Authors:  S Sell
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

7.  Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor.

Authors:  M Nagarkatti; P S Nagarkatti; A M Kaplan
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.

Authors:  R N Germain; R M Williams; B Benacerraf
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

9.  Immunosuppressive activity of sera from gastric cancer patients.

Authors:  M Sakita; T Torii; S Imaki; M Kasuga; M Tamai; G Suzuki; M Kano; Y Fujita; S Majima
Journal:  Jpn J Surg       Date:  1984-03

10.  The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; G Pastoor; N G Orie
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.